496 related articles for article (PubMed ID: 30961544)
1. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
[TBL] [Abstract][Full Text] [Related]
2. Role of Hydration in Contrast-Induced Nephropathy in Patients Who Underwent Primary Percutaneous Coronary Intervention.
Wang Z; Song Y; A G; Li Y
Int Heart J; 2019 Sep; 60(5):1077-1082. PubMed ID: 31447466
[TBL] [Abstract][Full Text] [Related]
3. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
Elgendy IY; Wen X; Mahmoud A; Bavry AA
Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
[TBL] [Abstract][Full Text] [Related]
4. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
Chatterjee S; Kundu A; Mukherjee D; Sardar P; Mehran R; Bashir R; Giri J; Abbott JD
Catheter Cardiovasc Interv; 2017 Aug; 90(2):205-212. PubMed ID: 28112470
[TBL] [Abstract][Full Text] [Related]
5. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
[TBL] [Abstract][Full Text] [Related]
6. Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
Leone AM; De Caterina AR; Sciahbasi A; Aurelio A; Basile E; Porto I; Trani C; Burzotta F; Niccoli G; Mongiardo R; Mazzari MA; Buffon A; Panocchia N; Romagnoli E; Lioy E; Rebuzzi AG; Crea F
EuroIntervention; 2012 Nov; 8(7):839-47. PubMed ID: 23171803
[TBL] [Abstract][Full Text] [Related]
7. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.
Duan N; Zhao J; Li Z; Dong P; Wang S; Zhao Y; Wang L; Wang H
Med Sci Monit; 2015 Jan; 21():292-7. PubMed ID: 25613017
[TBL] [Abstract][Full Text] [Related]
8. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.
Wolff G; Lin Y; Quade J; Bader S; Kosejian L; Brockmeyer M; Karathanos A; Parco C; Krieger T; Heinen Y; Perings S; Albert A; Icks A; Kelm M; Schulze V
Clin Res Cardiol; 2020 Feb; 109(2):235-245. PubMed ID: 31236693
[TBL] [Abstract][Full Text] [Related]
9. Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
Batchelor R; Liu DH; Bloom J; Noaman S; Chan W
Catheter Cardiovasc Interv; 2020 Jul; 96(1):76-88. PubMed ID: 31654491
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
[TBL] [Abstract][Full Text] [Related]
12. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Çınar T; Tanık VO; Aruğaslan E; Karabağ Y; Çağdaş M; Rencüzoğulları İ; Keskin M
Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
[TBL] [Abstract][Full Text] [Related]
13. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
[TBL] [Abstract][Full Text] [Related]
14. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
[TBL] [Abstract][Full Text] [Related]
15. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
[TBL] [Abstract][Full Text] [Related]
16. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis.
He H; Chen XR; Chen YQ; Niu TS; Liao YM
J Interv Cardiol; 2019; 2019():2750173. PubMed ID: 31772520
[TBL] [Abstract][Full Text] [Related]
18. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Kurtul A; Duran M
Clin Cardiol; 2017 Apr; 40(4):235-242. PubMed ID: 28244599
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
Yildiz I; Yildiz PO; Rencuzogullari I; Karabag Y; Cagdas M; Burak C; Gurevin MS
Angiology; 2019 Aug; 70(7):627-632. PubMed ID: 30712366
[TBL] [Abstract][Full Text] [Related]
20. Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
Vaidya SR; Qamar A; Arora S; Devarapally SR; Kondur A; Kaul P
Coron Artery Dis; 2018 Mar; 29(2):151-160. PubMed ID: 29120880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
